We are live on ! Find out more
HUMA icon

Humacyte

69 hedge funds and large institutions have $37.4M invested in Humacyte in 2023 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 23 increasing their positions, 18 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

271% more call options, than puts

Call options by funds: $152K | Put options by funds: $41K

49% more capital invested

Capital invested by funds: $25.1M → $37.4M (+$12.4M)

28% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 18

0.08% more ownership

Funds ownership: 11.59%11.67% (+0.08%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

8% less funds holding

Funds holding: 7569 (-6)

33% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 18

Holders
69
Holders Change
-6
Holders Change %
-8%
% of All Funds
1.1%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
12
Increased
23
Reduced
18
Closed
18
Calls
$152K
Puts
$41K
Net Calls
+$111K
Net Calls Change
+$113K
Name Holding Trade Value Shares
Change
Change in
Stake
Susquehanna International Group
26
Susquehanna International Group
Pennsylvania
$96.9K +$12.4K +4,372 +16%
SG Americas Securities
27
SG Americas Securities
New York
$92K +$85.1K +29,921 New
PAG
28
Private Advisor Group
New Jersey
$91.2K
Osaic Holdings
29
Osaic Holdings
Arizona
$90.4K +$4.21K +1,481 +5%
AIG
30
American International Group
New York
$87.7K +$1.61K +565 +2%
Millennium Management
31
Millennium Management
New York
$86K +$79.3K +27,875 New
Invesco
32
Invesco
Georgia
$71.8K -$8.91K -3,133 -12%
California State Teachers Retirement System (CalSTRS)
33
California State Teachers Retirement System (CalSTRS)
California
$67.5K -$147K -51,568 -70%
VOYA Investment Management
34
VOYA Investment Management
Georgia
$65.4K
UBS Group
35
UBS Group
Switzerland
$63.6K +$49.7K +17,470 +561%
SC
36
Shay Capital
New York
$61.8K -$1.92K -675 -3%
RJA
37
Raymond James & Associates
Florida
$60K +$55.2K +19,411 New
AllianceBernstein
38
AllianceBernstein
Tennessee
$55.3K +$6.82K +2,400 +15%
Allspring Global Investments
39
Allspring Global Investments
North Carolina
$50.9K +$46.9K +16,479 New
Manulife (Manufacturers Life Insurance)
40
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$47K
New York State Common Retirement Fund
41
New York State Common Retirement Fund
New York
$45.5K +$1.04K +367 +3%
YIH
42
Y-Intercept (HK)
Hong Kong
$45K +$41.4K +14,565 New
Wells Fargo
43
Wells Fargo
California
$44K +$32.1K +11,302 +383%
ProShare Advisors
44
ProShare Advisors
Maryland
$43.5K -$5.76K -2,025 -13%
Brown Advisory
45
Brown Advisory
Maryland
$40.6K
T. Rowe Price Associates
46
T. Rowe Price Associates
Maryland
$38K +$34.1K +12,004 New
Kovitz Investment Group Partners
47
Kovitz Investment Group Partners
Illinois
$35K +$32K +11,250 New
ACM
48
AlphaStar Capital Management
North Carolina
$33.3K
PTC
49
Philadelphia Trust Company
Pennsylvania
$31K
AB
50
Amalgamated Bank
New York
$25K -$7.1K -2,498 -24%

HUMA Hedge Fund Activity: Q1 2023 in Review

69 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Humacyte (HUMA) for Q1 2023, worth a combined $37.4M — up 49% from $25.1M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of HUMA and 12 opened new positions — a net loss of 6 holders — while 18 trimmed existing stakes and 23 added.

The largest buyer was Geode Capital Management, adding an estimated $508K. The largest seller was BlackRock, cutting an estimated $589K.

  • 69 institutional investors held Humacyte (HUMA) as of Q1 2023, down from 75 in Q4 2022.
  • Funds reported $37.4M of Humacyte stock for Q1 2023, up 49% quarter-over-quarter.
  • 12 funds opened new Humacyte positions in Q1 2023 and 18 closed out, a net change of -6 holders.
  • The largest Humacyte buyer in Q1 2023 was Geode Capital Management, an estimated $508K added.
  • The largest Humacyte seller in Q1 2023 was BlackRock, an estimated $589K sold.

Based on aggregated 13F filings for Q1 2023.